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Conventional human embryonic stem cells are
considered to be primed pluripotent but can be
induced to enter a naive state. However, the tran-
scriptional features associated with naive and
primed pluripotency are still not fully understood.
Here we used single-cell RNA sequencing to charac-
terize the differences between these conditions. We
observed that both naive and primed populations
were mostly homogeneous with no clear lineage-
related structure and identified an intermediate sub-
population of naive cells with primed-like expression.
We found that the naive-primed pluripotency axis is
preserved across species, although the timing of
the transition to a primed state is species specific.
We also identified markers for distinguishing human
naive and primed pluripotency as well as strong co-
regulatory relationships between lineage markers
and epigenetic regulators that were exclusive to
naive cells. Our data provide valuable insights into
the transcriptional landscape of human pluripotency
at a cellular and genome-wide resolution.
INTRODUCTION
Human and mouse embryonic stem cells (ESCs) are both
derived from the inner cell mass (ICM) of the pre-implantation
epiblast but differ in transcriptomic, epigenetic, and morpholog-
ical features that correspond to consecutive stages of ontogeny.
Mouse ESCs (mESCs) are marked by early developmental char-
acteristics such as expression of the core pluripotency network,
including Oct4, Klf4, or Dppa3; the activity of both X chromo-
somes in females; global DNA hypomethylation; and apolarCell Re
This is an open access article under the CC BY-Nmorphology of the dome-shaped mESC colonies and, therefore,
show the characteristics of naive pluripotency (Boroviak and
Nichols, 2017). In contrast, primed or conventional human
ESCs (hESCs) are developmentally more advanced and
resemble murine post-implantation epiblast or mouse epiblast
stem cells, thus they are considered to be primed pluripotent
(Brons et al., 2007; Tesar et al., 2007).
Several groups have aimed to capture naive pluripotency in
humans and to establish culture conditions closely recapitulating
the signature of human ICM cells. These studies attempted to
induce a naive state in hESCs by reprogramming primed hESCs
with cytokines or small molecules (Gafni et al., 2013; Hanna
et al., 2010; Takashima et al., 2014; Theunissen et al., 2014;
Ware et al., 2014) or by directly culturing hESCs isolated from
pre-implantation ICM cells under conditions that favor naive
stemness (Guo et al., 2016). Among these, the stimulation of
NANOG and KLF2 expression in 2 inhibitors (PD0325901 and
CHIR99021) + Leukemia inhibitory factor (2i+Lif) conditions (inhi-
bition of mitogen-activated protein extracellular signal-regulated
kinase [ERK] and glycogen synthase kinase-3 beta) and subse-
quent restriction of protein kinase C (PKC) activity yielded hESCs
with a close resemblance to the human blastocyst (Guo et al.,
2017; Huang et al., 2014; Takashima et al., 2014). These reprog-
rammed naive hESCs express naive pluripotency markers,
including OCT4, SOX2, and KLF2 and KLF4 (Boroviak and Nich-
ols, 2017), and their metabolic and epigenetic profiles resemble
the phenotype of mESCs rather than the primed state of conven-
tional hESCs (Takashima et al., 2014).
There is still incomplete understanding of the transcriptional
features that drive naive and primed pluripotency in ESCs
(Ware, 2017; Weinberger et al., 2016). Studies exploring tran-
scriptional identity and heterogeneity in mESCs have found sig-
nificant variability associatedwith different states of pluripotency
(Klein et al., 2015; Kolodziejczyk et al., 2015; Kumar et al.,
2014). In a recent in vivo study of early mouse development
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to contribute to cell fate decision-making. However, although
certain key pluripotency genes are much less variably expressed
in the naive state (e.g., NANOG), single-cell RNA sequencing
(scRNA-seq) suggests that overall heterogeneity in gene expres-
sion in mESC lines is independent of the respective culture con-
dition and pluripotency state (Kolodziejczyk et al., 2015).
Our understanding of in vivo lineage commitment in humans
is much more limited. By studying transcriptional profiles of
developmental stages embryonic day 3 (E3) to E7 of human
preimplantation embryos, the first lineage decisions between
trophectoderm, primitive endoderm, and epiblast have been
described (Petropoulos et al., 2016; Stirparo et al., 2018).
Furthermore, a recent study has investigated the primed-to-
naive cellular state transition process and found that genes
related to hemogenic endothelium development were overrepre-
sented in naive hESCs, resulting in higher differentiation potency
into hematopoietic lineages (Han et al., 2018). Nonetheless, the
extent and details of hESC heterogeneity have not been system-
atically characterized, and it is unclear whether the variability in
gene expression is important for differentiation. To address
these questions, we performed scRNA-seq of primed hESCs
and reprogrammed naive hESCs to investigate the heterogeneity
within each subpopulation and to compare their molecular phe-
notypes with in vivo transcriptome studies of embryogenesis.
RESULTS
Weassayed the transcriptomes of single primed and naive hESCs
(WiCell WA09-NK2) to investigate gene expression heterogeneity
and to identify potential subpopulations within different human
pluripotency states. In total, we collected 480 hESCs grown under
naı¨ve titrated 2 inhibitors (PD0325901 and CHIR99021) + Leuke-
mia inhibitory factor + inhibitor Go¨6983 (t2iL+Go¨) conditions (Ta-
kashima et al., 2014) and 480 hESCs grown under primed (E8)
culture conditions (Chen et al., 2011). Single cells were separated
and collected using fluorescence-activated cell sorting (FACS),
and full-length cDNAswereprepared using the switchmechanism
at the 50 end of RNA templates (Smart-seq2) protocol (Picelli et al.,
2014), followed by Nextera XT library preparation (Figure 1A). We
removed low-quality cells and normalized for cell-specific bias
prior to further analyses (STAR Methods; Figure S1A).
Naive and Primed hESCs Form Distinct Phenotypic
Clusters
To confirm that scRNA-seq can recapitulate known differences
between naive and primed conditions, we performed dimension-
ality reductiononall cells in thedataset usingprincipal-component
analysis (PCA) on highly variable genes (STAR Methods). We
observed strong separation between naive and primed cells on
the first principal component (Figure 1B), indicating that the differ-
encebetweenconditions is thedominant factor of variation.Differ-
ential expression analysis between naive and primed conditions
identified a number of genes that were strongly upregulated under
each condition (Figure 1C). This included the previously reported
naive pluripotency and ground state marker genes KLF17,
DPPA5,DNMT3L,GATA6,TBX3, IL6ST,DPPA3, andKLF5 (Blake-
ley et al., 2015; Dunn et al., 2014; Guo et al., 2017; Shahbazi et al.,
2016; Theunissen et al., 2016; Yan et al., 2013). AlthoughKLF4has816 Cell Reports 26, 815–824, January 22, 2019been described as amarker for both naive and primed cells (Ware,
2017), we only observed its expression in naive hESCs, consistent
with other studies (Weinberger et al., 2016). In primed hESCs, we
observedupregulation of establishedmarker genes of primedplu-
ripotency, such as CD24, ZIC2, and SFRP2, but not OTX2 or TFT
(Buecker etal., 2014;Guoetal., 2016;Shakibaetal., 2015).Shared
pluripotency markers, including SOX2, OCT4, and NANOG, did
not significantly differ between the naive and primed population.
We also identified additional (and only recently suggested;
Collier et al., 2017) markers of naive and primed hESCs (Table 1;
Figure S1B; Table S1). The naive markers included genes that
have been implicated in germ cell function (e.g., HORMAD1 for
meiotic progression; Chen et al., 2005); KHDC3L as a regulator
of imprinting (Parry et al., 2011); the alkaline phosphatases
ALPP and ALPPL2, which are generally used as markers of
pluripotent cells (Martı´ et al., 2013); as well as putative regulatory
genes such as ZNF729. Some of these are also expressed in the
early embryo; e.g., TRIM60 (Choo et al., 2002) and HORMAD1
(Chen et al., 2005). Primed markers included a number of genes
related to later developmental stages; e.g., SOX11 for neuronal
development (Bergsland et al., 2006),CYTL1 for chondrogenesis
and expressed at implantation (Ai et al., 2016),HMX2 (an NK-like
[NKL] homeobox gene) for organogenesis (Wang et al., 2001),
and THY1 for hematopoietic stem cells (Majeti et al., 2007).
We also found regulators of key signaling pathways, such as
DUSP6 (a negative regulator of mitogen-activated protein kinase
[MAPK] signaling) (Muda et al., 1996) and the receptor tyrosine
phosphatase PTPRZ1 (Levy et al., 1993). We validated a number
of these genes at the protein level using proteomics (Figure S1C)
and in bulk RNA-seq data of the hESC lines UCLA1, WIBR3, and
SHEF6 under naive and primed conditions (Table 1; Figure S1D;
Pastor et al., 2016; Theunissen et al., 2016; Guo et al., 2017).
Identification of a Subcluster in the Naive hESCs
Population
We observed a small group of naive cells between the main naive
and primed clusters (Figure 1B). We identified these cells by hier-
archical clusteringwithin the naive population, yielding a separate
cluster of 9 cells. Despite being labeled as naive, this cluster was
distinguishable from the other cells in the naive population as well
as from the primed population (Figure 2A). These cells expressed
some naive markers (DPPA3 and TFCP2L1; Figure 2B) but also
exhibited primed-like characteristics (downregulation of KLF4
and KLF7) (Figure S2A); thus we labeled them ‘‘intermediate.’’
This subpopulation does not consist of doublets from the sin-
gle-cell sorting procedure because they uniquely express genes
that are absent in the primed population and other naive cells.
One question is whether this intermediate population arises
from primed cells that were not fully transformed into the naive
state or from naive cells that have acquired a more primed state.
To investigate this, we specifically examined the expression of
imprinted genes such as MEG3, PEG3, and SNRPN. Loss of
imprinting has been reported under all current naive hESCs cul-
ture conditions, whereas conventional hESCs rarely show
imprinting defects (Guo et al., 2017, 2016; Pastor et al., 2016).
When lost, imprinting cannot be restored in non-germline cells,
which can directly affect the expression level of the imprinted
genes. We found similar expression of imprinted genes in the
Figure 1. Naive and Primed Human ESCs Exhibit Strong Differences in Gene Expression
(A) Naive and primed human ESCs were cultured in N2B27 supplemented with t2iL+Go¨ or in E8 medium, dissociated into single cells, and sorted into 96-well
plates loaded with RLT lysis buffer and External RNAControls Consortium (ERCC) spike-ins. RNA-seq libraries were prepared using the SmartSeq2 protocol and
submitted for sequencing.
(B) PCA plot of hESC expression profiles, constructed from batch-corrected and normalized log expression values of highly variable genes detected across the
entire dataset. Cells are colored by their condition, and the percentage of variance explained by the first two principal components is shown.
(C) Smear plot of log2-fold changes in expression between the naive and primed conditions, where differential expression (DE) genes were detected using edgeR
at a false discovery rate (FDR) of 5%.
See also Figure S1 and Table S1.intermediate cluster compared with naive hESCs (Figure S2B),
indicating that the subpopulation cells originate from the naive
cells rather than being reprogramming-refractory remnants of
the primed population that would not yet have undergone global
DNA demethylation and loss of imprinting.
A number of genes were also uniquely upregulated in the inter-
mediate population compared with both the naive and primed
population. This includes ABCG2, CLDN4, VGLL1, GATA2,
GATA3, and ERP27 (Figure S2C; see Table S2 for the full list),
with significant over-representation of genes involved in
morphological structure formation, development, and signaling
(see Figure S2D for the Gene Ontology [GO] analysis). This sug-
gests that the intermediate population is a separate state from
the naive and primed conditions. Indeed, the transcription ofNANOGwas strongly downregulated in the intermediate popula-
tion compared with both naive and primed cells (Figure 2B). In
this respect, the subpopulation state shares some transcrip-
tional features with the recently proposed state of formative plu-
ripotency (Smith, 2017). Immunofluorescence staining based on
high expression of ABCG2 and low expression of DPPA5 sup-
ported the existence of the intermediate population within the
naive condition (Figures 2C and 2D).
Subclusters with Lineage-Specific Gene Expression
Profiles Are Not Present in Naive or Primed hESCs
To study transcriptional heterogeneity within the naive and
primed conditions, we applied t-distributed stochastic neighbor
embedding (t-SNE) (van der Maaten and Hinton, 2008) to theCell Reports 26, 815–824, January 22, 2019 817
Table 1. Markers of Naive and Primed Pluripotency in hESCs
Naive
logFC
(WA09-NK2)
logFC*
(UCLA1)a
logFC*
(WIBR3)b
logFC*
(SHEF6)c Primed
logFC*
(WA09-NK2)
logFC*
(UCLA1)a
logFC*
(WIBR3)b
logFC*
(SHEF6)c
KHDC1L 14.49 8.82 13.23 9.36 DUSP6 13.88 6.29 9.69 7.09
FAM151A 14.13 7.57 10.49 9.20 FAT3 9.80 8.44 10.76 7.65
HORMAD1 15.03 7.09 10.94 10.25 THY1 13.60 8.78 8.47 6.26
ALPPL2 20.17 7.32 11.26 8.82 STC1 11.82 8.79 12.14 7.57
ZNF729 14.07 4.25 11.15 4.83 KLHL4 12.58 7.10 13.17 5.09
KHDC3L 19.58 6.88 12.78 9.54 ZDHHC22 15.53 9.02 7.86 9.44
TRIM60 18.53 7.90 12.19 8.33 NEFM 13.20 4.64 7.33 5.26
MEG8 17.57 8.23 8.89 not DE HMX2 10.58 not DE not DE not DE
OLAH 10.80 7.58 12.87 7.97 PLA2G3 15.29 6.31 5.74 8.07
LYZ 17.31 5.47 7.94 4.70 PTPRZ1 10.55 8.33 12.72 9.63
HYAL4 17.01 5.92 9.13 5.66 CYTL1 14.54 7.60 9.43 9.09
ALPP 16.58 4.55 10.03 9.29 SOX11 10.20 6.33 8.60 4.97
*Log fold change between the primed and naive population; adjusted p < 0.005 for all shown DE genes.
aPastor et al. (2016)
bTheunissen et al. (2016)
cGuo et al. (2017)cells under each condition after removing all intermediate popu-
lation cells from the naive condition. We did not observe any
distinct clustering within each condition; instead, themajor driver
of heterogeneity in each conditionwas the cell cycle (Figure S3A).
To focus only on heterogeneity related to embryonic develop-
ment, we constructed the t-SNE plots using only a set of 184
endoderm-, ectoderm-, and mesoderm-specific markers (Table
S3). The aim was to enrich for any weak population structure
related to early fate commitment. However, we still did not
observe any clusters corresponding to the different germ layers
in either the naive or primed populations (Figures 3A, 3B, and
S3B). This suggests that the primed cells remain in a mostly ho-
mogeneous undifferentiated state and have yet to begin the pro-
cess of committing to differentiate into the germ layers.
The homogeneity of both the naive and primed conditions sug-
gests that it is possible to explore co-regulatory relationships via
gene-gene correlations within each population. In particular, we
focused on epigenetic modulators because of their importance
in controlling cellularmemory and their relevance for early embry-
onic development.Within each condition, we computed pairwise
correlations between the expression profiles of 704 epigenetic
modulators with a set of 94 developmental markers (Table S4;
Figure S3C). We observed strong correlations in the naive popu-
lation (Figure 3C) thatweremuchweaker in theprimedpopulation
(Figure 3D). This indicates that the expression of the epigenetic
machinery is more distinctly linked to the naive gene expression
network andparticularly to regulators related todenovoDNAand
histone methylation (e.g., DNMT3A/B and EHMT1).
A Naive-to-Primed Axis Can Identify Pluripotency
Transitions in Other Species
To integrate our data with previous in vivo studies, we defined a
naive-to-primed axis based on empirically defined marker genes
that were strongly differentially expressed between the two con-
ditions (STAR Methods). Cells from other scRNA-seq datasets
were mapped onto this axis based on the proportion of naive-818 Cell Reports 26, 815–824, January 22, 2019primed markers (or homologous equivalents in non-human
data) they expressed. As a proof of concept, we mapped the
previously described intermediate population onto the naive-
to-primed signature map (Figure S4A). The subpopulation
hESCs were located close to the naive axis but expressed a
lower proportion of signature markers than the residual naive
population. This is consistent with our hypothesis that the inter-
mediate population originates from naive cells but has lost some
features of naive pluripotency.
Next we mapped published scRNA-seq datasets of pre-
implantation embryos from mice (Mohammed et al., 2017),
cynomolgusmonkeys (Nakamura et al., 2016), and humans (Pet-
ropoulos et al., 2016) onto our naive-to-primed axis. For mouse
and monkey embryos, we observed a gradual loss of naive
marker expression and an increase in primed marker expression
(Figures 4A and 4B). This is consistent with the transition from
naive to primed pluripotency and suggests that the relevant
genes are conserved across species. Equal proportions of
naive-primed markers were expressed at approximately E5
(mice) and E9–E13 (monkeys). In contrast, we did not observe
any clear shift to primed pluripotency in humans before E7 (Fig-
ure 4C), consistent with the similarity of in vivo naive pluripotency
with in vitro reprogrammed naive pluripotency under the applied
culture conditions (Takashima et al., 2014).
We also defined a naive-to-intermediate axis using the identi-
fied uniquemarkers of our intermediate population instead of the
primed markers. We observed a shift from the naive expression
pattern to that of the intermediate population after E5 in the
human data (Figure S4B). This suggests that the intermediate
population may also be present in vivo and relevant to human
embryonic development.
DISCUSSION
By sequencing the transcriptomes of single naive and primed
hESCs, we identified discrete expression signatures of the two
Figure 2. The Naive Subpopulation Is Transcriptionally Distinct from the Other Naive and Primed Cells
(A) Heatmap of the top 50 genes with the strongest differential expression between the naive and intermediate cells (top) or between the intermediate and primed
cells (bottom). The box for each cell (column) and gene (row) is colored according to the log2-fold change from the average expression for each gene.
(B) Log2 expression profiles of selected marker genes across cells in the naive, intermediate, and primed populations. Each point represents a cell in the
corresponding population.
(C) Normalized protein expression of DPPA5 against ABCG2 in naive and primed hESCs. Protein expression was determined using immunofluorescence staining
of cytospin-fixed cells.
(D) Representative immunofluorescence images of naive and primed hESCs using DPPA5 and ABCG2 antibodies. The scale bar represents 20 mm.
See also Figure S2 and Table S2.pluripotency states. In addition to recovering existing markers
(Ware, 2017; Weinberger et al., 2016), we defined genes that
are highly specific to each population. These expressionmarkers
are well conserved across species, as we were able to show by
mapping mouse, monkey, and human sequencing data onto our
naive-to-primed signature axis.
Another aim of this study was to clarify the heterogeneity and
developmental progression of each pluripotency state in
hESCs. We found that both naive and primed states of cultured
hESCs were comparably homogeneous, except for a small
subpopulation of cells in the naive state with transcriptional
features of primed pluripotency. This was surprising because
the primed state was expected to be more differentiated and
possibly showing signatures of early lineage commitments, assuggested by in vivo work in mice (Mohammed et al., 2017).
However, the comparably low levels of heterogeneity of naive
and primed pluripotency in vitro have also been observed in
mESC lines (Kolodziejczyk et al., 2015) and could be a reflec-
tion of the medium favoring one particular cellular phenotype.
Therefore, these artificial states may be a misleading represen-
tation of primed pluripotency, which is more heterogeneous
in vivo.
We observed that cell cycle-related effects were the most
prominent source of variability within both the naive and the
primed population. It is possible that specific cell cycle states
may play a major role in contributing to cell fate decisions by
introducing transcriptional noise. We also found that naive
hESCs showed stronger correlations of pluripotency andCell Reports 26, 815–824, January 22, 2019 819
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Figure 3. Naive and Primed Populations Do Not Exhibit Lineage-Associated Structure, but Correlations between Lineage Markers and
Epigenetic Regulators Are Stronger under the Naive Condition
(A and B) Gene expression of germ layer-specific marker genes in the (A) naive and (B) primed population, visualized using tSNE on the batch-corrected
normalized log expression values. Each point in the scatterplot represents a cell, which is colored by the expression of respective mesoderm (SNAI1), ectoderm
(ITGA6), or endoderm (PAF1) markers.
(C and D) Heatmaps of the strongest correlation values between selected pluripotency and lineagemarkers (rows) and epigenetic markers (columns) for the naive
(C) and the primed (D) population. The correlation values were bound at [0.5, 0.5].
See also Figure S3 and Tables S3 and S4.lineage markers to epigenetic regulators than primed hESCs.
Given the major epigenetic resetting observed during early em-
bryonic development (i.e., from fertilization to the formation of
the naive ICM cells; Iurlaro et al., 2017), the naive transcriptional
state may have a unique need to be tightly coupled to the
expression of the epigenetic machinery. In contrast, primed
hESCs represent a later developmental stage in which the
epigenetic machinery may be less strictly controlled as the
epigenome is re-established in a more heterogeneous and cell
type-specific manner. Future work exploring the epigenetic
dynamics in early mouse and human embryonic development
by single-cell epigenomics will help to dissect these mecha-
nisms in more detail.
We also identified a subpopulation of naive hESCs that
showed both features of naive and primed states. Indeed, we
assume that the naive state in hESCs is temporally limited and
that cells are prone to exit it. The existence of ‘‘formative’’ plu-
ripotency has recently been suggested (Smith, 2017). This state820 Cell Reports 26, 815–824, January 22, 2019may represent a cellular phase where cells acquire differentia-
tion competency and are marked by the expression of early
post-implantation factors such as OTX2, SOX3, and POU3F1
and the transient loss of NANOG expression. Interestingly,
the intermediate population is characterized by significantly
decreased NANOG transcription, although we did not detect
significant upregulation of OTX2, SOX3, and POU3F1. It re-
mains to be seen whether this subpopulation corresponds to
cells exiting naive pluripotency toward formative pluripotency
and whether this represents a real in vivo state or arises
because of culture-specific conditions.
Our study provides important insights into the transcriptomic
heterogeneity of naive and primed hESCs. The identification of
specific markers may contribute to studying the reprogramming
dynamics during the primed-to-naive transitions and delineate
key transcriptional events leading to human naive pluripo-
tency. Finally, we catalog and compare pluripotency identity
across species to characterize transitions between different
AB
C
(legend on next page)
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pluripotency states that mark specific temporal windows of em-
bryonic development.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
HumanWA09-NK2 ESCs (Takashima et al., 2014) were kindly provided by Austin Smith and grown under naive or primed conditions.
METHOD DETAILS
Cell culture and collection
Naive hESCswere grown in 6-well dishes onmouse embryonic fibroblasts in N2B27 supplementedwith human LIF, 1mMChiron, 1mM
PD03 and 2mM Go¨6983. 1 passage before sorting, cells were plated on 6-well plates coated with Matrigel (growth-factor reduced).
Primed hESCs were grown in 6-well dishes coated with Vitronectin in E8 media. For collection, hESCs were dissociated with Accu-
tase and sorted in 96 well plates containing lysis buffer on a BD Aria Cell sorter, gating for cell size and granularity. In each plate,
4 wells were left empty as negative controls. Plates were immediately spun down and frozen at 80C until subsequent processing.
This was performed in two batches – the first batch contained 96 cells from each condition, while the second batch contained
384 cells from each condition (480 cells in total per condition).
Library preparation and sequencing
Single-cells were sorted in 2uL of Lysis Buffer (0.2% v/v Triton X-100 (Sigma-Aldrich, cat. no. T9284) with 2U/ul RNase Inhibitor
(Clontech, cat. no. 2313A)) in 96 well plates, spun down and immediately frozen at80C. cDNA from sorted single cells was prepared
following the SmartSeq2protocol (Picelli et al., 2014).Briefly,oligo-dTprimer,dNTPs (ThermoFisher, cat. no.10319879) andERCCRNA
Spike-InMix (1:25,000,000final dilution, Ambion, cat. no. 4456740)wereadded to the single-cell lysates, andReverse Transcription and
PCRwereperformed. The cDNA libraries for sequencingwerepreparedusingNexteraXTDNASamplePreparationKit (Illumina, cat. no.
FC-131-1096), according to the protocol supplied by Fluidigm (PN 100-5950B1). Libraries from96 single cellswere pooled and purified
using AMPure XP beads (Beckman Coulter). Pooled samples were sequenced on an Illumina HiSeq 2500 instrument, using paired-end
100-bp reads. On average, we obtained 2.13 106 reads per cell in batch 1 and 0.53 106 reads per cell in batch 2.
Immunofluorescence Analysis
Antibody staining was performed as previously described (Santos et al., 2003). Briefly, hESCs were cytospun, after fixation with 2%
PFA for 30 minutes at room temperature. Cells were permeabilised with 0.5% Triton X-100 in PBS for 1h; blocked with 1% BSA in
0.05%Tween20 in PBS (BS) for 1h; incubation of the appropriate primary antibody diluted in BS; followed by wash in BS and
secondary antibody. Secondary antibody was Alexa Fluor conjugated (Molecular Probes) diluted 1:1000 in BS and incubated for
30 minutes. Incubations were performed at room temperature unless otherwise stated. DNA was counterstained with 5 mg/mL
DAPI in PBS. Single optical sections were captured with a Zeiss LSM780 microscope (63x oil-immersion objective). Fluorescence
semi-quantification analysis was performed with Volocity 6.3 (Improvision).
QUANTIFICATION AND STATISTICAL ANALYSIS
Alignment and read counting
Read pairs were aligned to a reference consisting of the hg38 build of the human genome as well sequences for the ERCC spike-in
transcripts. This was performed using the subread aligner v1.6.0 (Liao et al., 2013) in paired-end mode with unique alignment. Eache2 Cell Reports 26, 815–824.e1–e4, January 22, 2019
read pair was then assigned to a gene in the Ensembl GRCh38 v91 annotation or to the spike-in transcripts. This was done using the
featureCountsfunction in the Rsubread package v1.28.1 (Liao et al., 2014). Only reads with mapping quality scores above 10 were
used for counting. Read counts from technical (sequencing) replicates of the same cell were added together prior to further analysis.
On average, over 71% of reads mapped to the genome with over 59% mapped to exons.
Quality control on cells and genes
A range of quality metrics were computed for each cell (Figure S1A) using the calculateQCMetrics function in the scater package
v1.6.3 (McCarthy et al., 2017). For each metric, outlier values were identified as those that were more than three median absolute
deviations from the median. Low quality cells were identified in each batch, as those with small outlier values for the log-transformed
total count; small outliers for the log-transformed number of expressed genes; large outliers for the proportion of read pairs assigned
to mitochondrial genes; or large outliers for the proportion of read pairs assigned to spike-in transcripts. These cells were removed
from the dataset prior to further analysis, leaving 414 naive and 423 primed cells remained for downstream analysis.
The cell cycle phase for each cell was identified using the cyclone classifier (Scialdone et al., 2015) implemented in the scran pack-
age v1.6.9. This was performed with a set of human marker genes, identified by training the classifier on a pre-existing hESC dataset
(Leng et al., 2015).
Normalization of cell-specific biases
For the endogenous genes, cell-specific size factors were computed using the deconvolution method (Lun et al., 2016a) with pre-
clustering. For each gene, the count for each cell was divided by the appropriate size factor. A pseudo-count of 1 was added,
and the value was log2-transformed to obtain log-normalized expression values. This was repeated using the spike-in transcripts,
where the size factor for each cell was proportional to the sum of counts for all spike-in transcripts (Lun et al., 2017).
Feature selection and dimensionality reduction
Feature selection was performed by computing the variance of the normalized log-expression values across cells for each endog-
enous gene or spike-in transcript. To represent technical noise, a mean-dependent trend was fitted to the variances of the spike-in
transcripts using the trendVar function in the scran package (Lun et al., 2016b). This was done separately for each batch of cells to
ensure that large variances were not driven by uninteresting batch effects. The decomposeVar function was used to obtain the bio-
logical component of the variance by subtracting the fitted value of the trend (i.e., the technical component) from the total variance of
each gene. The combineVar function was then used to consolidate statistics across batches.
Batch effects were removed from the log-expression matrix using the removeBatchEffects function from the limma package
v3.34.9 (Ritchie et al., 2015). This involved performing a linear regression on the log-expression profile of each gene and setting
the blocking term for the batch to zero, whichwas possible for this data due to the balanced naive-primed composition of each batch.
Principal component analysis was applied to the corrected expression matrix, only using the genes with positive biological compo-
nents. This was performed with the denoisePCA function from scran to determine the number of principal components to retain.
t-SNE was performed on the retained PCs using the Rtsne package v0.13.
Testing for differential expression between conditions
Counts for the naive and primed cells within each batch were pooled to obtain four sets of pseudo-bulk counts (Lun and Marioni,
2017). Low-abundance genes with average counts below 5 were removed and normalization was performed on the remainders
with the trimmed mean of M-values method (Robinson and Oshlack, 2010). Genes were tested for differential expression (DE)
between naive and primed conditions using the quasi-likelihood framework in the edgeR package v3.20.9 (Y. Chen et al., 2016).
The experimental design was parameterized using an additive design containing a condition term and the batch blocking factor.
DE genes were defined as those with significant differences between conditions at a FDR of 5%.
To validate the identified marker genes, DE genes in three different bulk RNA-seq datasets (Pastor et al., 2016; Theunissen et al.,
2016; Guo et al., 2017) were identified using the quasi-likelihood framework. This used the procedure described above with the only
difference being that DE genes were defined as having absolute log-fold changes significantly greater than 0.5 at a FDR of 5%
(McCarthy and Smyth, 2009). This ensured that the DE analysis focused on genes with strong differences in expression. The results
of the analysis for each dataset were visualized using volcano plots. For comparison, we highlighted the top 200 naive markers and
the top 200 primed markers from our single-cell data (ranked by p value) on each plot.
Detecting the intermediate population
Dimensionality reduction was performed as previously described using only the cells in the naive condition. The retained principal
components were used for hierarchical clustering of the cells with the hclust function in R, using Ward linkage on the Euclidean dis-
tances. Clusters of cells were identified using a simple tree cut, where the optimal number of clusters was determined by maximizing
the average silhouette width. The cluster of cells located between the bulk of cells from the naive and primed conditions in the PCA
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The intermediate population was characterized by testing for differential expression relative to the other naive cells or to the primed
cells. This was done using t tests on the log-expression values (Soneson and Robinson, 2018) after blocking on the batch. For each
contrast, several candidates were chosen from the top set of DE genes for further validation by immunofluorescence staining.
Exploring lineage-related heterogeneity
Dimensionality reduction was performed for each condition as previously described. For the naive condition, cells in the intermediate
population were removed. PCA plots were colored according to the expression of CDK1 to represent cell cycle activity (Figure S3A).
Dimensionality reduction in each condition was also repeated using only genes that were specific for the germ layers (Table S3) to
detect potential early lineage commitment. Again, cells in the intermediate population were excluded. The resulting t-SNE plots were
colored by expression of the mesoderm marker SNAI1 (Evseenko et al., 2010), the ectoderm marker ITGA6 (Brafman et al., 2013) or
the endodermmarker PAF1 (Ponnusamy et al., 2009) to visualize any lineage-related substructure and by the expression of cell-cycle
marker CDK1 (Figure S3C).
Correlations with epigenetic modulators
Pairwise correlations of selected lineage and pluripotency markers to epigenetic modulators (Table S4) were calculated using the
correlatePairs function from the scran package. This involved computing Spearman’s rank correlation coefficients between the
log-expression profiles of lineage marker genes (endoderm, ectoderm, mesoderm, trophectoderm, core pluripotency, naive plurip-
otency, formative pluripotency, primed pluripotency and germline) and genes comprising the epigenetic machinery. P-values for all
pairs were combined and corrected for multiple testing.
To visualize the correlations, we computed the average absolute correlation across naive and primed conditions for each gene pair.
We then selected the top 25 lineage/pluripotency markers and the top 25 epigenetic modifiers with the largest average absolute cor-
relations. For each condition, a heatmap of the correlation values between all pairs of the selected genes was constructed using the
pheatmap function from the pheatmap package v1.0.8.
Mapping temporal trajectories in early embryos
Naive marker genes were defined from our data as those that were DE relative to primed cells (using the pseudo-bulk statistics,
above) at a FDR of 5% and with a log2-fold change of 10; were present in at least 25% of naive cells; and were present in no
more than 5% of primed cells. Similarly, primed marker genes were defined as those that were DE relative to naive cells at a FDR
of 5% and with a log2-fold change of 10; were present in at least 25% of primed cells; and were present in no more than 5% of
naive cells.
A marker gene was considered to be expressed in a cell from a different dataset if its (normalized) count was greater than 10. For
each cell, we calculated the proportion of naive markers that were expressed. This was repeated for the primed markers. Cells were
mapped onto the ‘‘naı¨ve-primed axis’’ based on these proportions. Large naive proportions and small primed proportions indicate
that the cell is naive, and vice versa for primed cells.
Mapping onto the naive-primed axis was performed for cells collected from human pre-implantation embryos (Petropoulos et al.,
2016), mouse embryos (Mohammed et al., 2017), and cynomolgus monkey embryos (Nakamura et al., 2016). Mouse homologs for
the marker genes were identified using the getLDS function from the biomaRt package (Durinck et al., 2005), using the homology
relationships predicted by Ensembl. Monkey homologs for marker genes were identified as those with the same gene symbol. As
a control, we also performed remapping using the naive, primed and intermediate population cells in our own dataset.
To assess the expression of intermediate population genes in the human pre-implantation embryos (Petropoulos et al., 2016), an
intermediate-naive axis was constructed similarly to the naive-primed axis. Intermediate population marker genes were considered
uniquely expressed in the subpopulation by a log2-fold change of 5 against both the naive and the primed population at a FDR of 5%,
and by their presence in less than 25% of the naive and the primed cells.
DATA AND SOFTWARE AVAILABILITY
Code availability
All analysis code is available at https://github.com/MarioniLab/NaiveHESC2016.
Deposition of sequencing data
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